Disclosures for "Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED) ")
-
Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme.
-
Dr. Douglas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Therapeutics. Dr. Douglas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Douglas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon Therapeutics.
-
Dr. Cockerham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Cockerham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian Pharmaceuticals. Dr. Cockerham has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon therapeutics. Dr. Cockerham has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics. Dr. Cockerham has received research support from Viridian Pharmaceuticals.
-
Dr. Turbin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Turbin has received research support from Viridian.
-
Dr. Nijhawan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for College of Physicians and Surgeons of Ontario. Dr. Nijhawan has received research support from Viridian Therapeutics.
-
The institution of Dr. Schiffman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Schiffman has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for lAW FIRMS. Dr. Schiffman has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Ugradar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian Therapeutics. Dr. Ugradar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Valenza Bio.
-
Dr. Oshaughnessy has received personal compensation for serving as an employee of viridian therapeutics. Dr. Oshaughnessy has stock in viridian therapeutics.
-
Mrs. Summerfelt has received personal compensation for serving as an employee of Viridian Therapeutics. An immediate family member of Mrs. Summerfelt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viridian Therapeutics. Mrs. Summerfelt has stock in Viridian Therapeutics.
-
Dr. She has received personal compensation for serving as an employee of Viridian Therapeutics. Dr. She has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus Therapeutics. Dr. She has stock in Viridian Therapeutics.
-
Dr. Katz has received personal compensation for serving as an employee of Viridian Therapeutics. Dr. Katz has received stock or an ownership interest from Viridian Therapeutics.